| Literature DB >> 18292289 |
Liang Yu1, Abdalla J Mohamed, Oscar E Simonson, Leonardo Vargas, K Emelie M Blomberg, Bo Björkstrand, H Jose Arteaga, Beston F Nore, C I Edvard Smith.
Abstract
Bruton tyrosine kinase (Btk) is critical for B-cell development. Btk regulates a plethora of signaling proteins, among them nuclear factor-[kappa]B (NF-kappaB). Activation of NF-kappaB is a hallmark of B cells, and NF-kappaB signaling is severely compromised in Btk deficiency. We here present strong evidence indicating that NF-kappaB is required for efficient transcription of the Btk gene. First, we found that proteasome blockers and inhibitors of NF-kappaB signaling suppress Btk transcription and intracellular expression. Similar to Btk, proteasome inhibitors also reduced the expression of other members of this family of kinases, Itk, Bmx, and Tec. Second, 2 functional NF-kappaB-binding sites were found in the Btk promoter. Moreover, in live mice, by hydrodynamic transfection, we show that bortezomib (a blocker of proteasomes and NF-kappaB signaling), as well as NF-kappaB binding sequence-oligonucleotide decoys block Btk transcription. We also demonstrate that Btk induces NF-kappaB activity in mice. Collectively, we show that Btk uses a positive autoregulatory feedback mechanism to stimulate transcription from its own promoter via NF-kappaB.Entities:
Mesh:
Substances:
Year: 2008 PMID: 18292289 DOI: 10.1182/blood-2007-10-121137
Source DB: PubMed Journal: Blood ISSN: 0006-4971 Impact factor: 22.113